Indonesia – The main analyst of the Merah Putih Vaccine clinical preliminary at Airlangga University, (Unair) Surabaya, Dr. Dominicus Husada, SpA(K) affirmed that the immunization improvement interaction will arrive at deliberately ease three of the clinical preliminary in June 2022. In view of this, Clinical preliminaries will run by plan. Presently, they are getting ready for stage 3. Along with …

Indonesia – The main stage clinical preliminary of the locally delivered Merah Putih antibody is an immense jump for free immunization advancement in Indonesia, the National Research and Innovation Agency (BRIN) head Laksana Tri Handoko has said. This is a gigantic jump, for the Unair (Airlangga University) group, yet additionally for the other six Merah Putih immunization groups. The main …

The controversial and on the hot spot Sinovac of China has obtained permission for its coronavirus vaccine to hold clinical trials in the region, local regulators. These tests, including a certain number of patients, are performed to assess if candidate vaccines are safe and reliable for the lethal virus that has infected and killed millions. Last year, five drugmakers had …

Indonesia has sought a report from Brazil, where a similar study is going smoothly in terms of the sluggish advancement of its own Phase 3 clinical trial of a COVID-19 vaccine candidate. They are looking forward to collect safety and efficacy data by the end of this month on the Chinese company which is Sinovac Biotech’s CoronaVac, and hoping to …

METRO MANILA – One of China’s candidate vaccine for COVID-19 has been cleared by the country for Phase 3 clinical trial that is expected to start by November. According to the Food and Drug Administration director general Eric Domingo the vaccine expert panel from the  Department of Science and Technology (DOST) has given the vaccine the green light to proceed …

METRO MANILA – The Food and Drug Administration (FDA) has assured the public that before the vaccine be made available, the government will make sure the public safety is the utmost priority and that caution will be strictly observed in the vaccine registration. The FDA is expecting a vaccine to be approved for use in the country by April 2021. …